Angelini Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control and infectious diseases and central nervous system (CNS) diseases and disorders. It focuses its research work primarily in the therapeutic areas of travelers diarrhea, chronic bacterial prostatitis, major depressive disorder, diabetic neuropathy, pain, inflammation, bacterial infections and others. Angelini also designs, constructs and installs integrated production lines for disposable sanitary products; offers absorbent products for personal care and operates in wine and perfume sector through its business units. Angelini is headquartered in Rome, Italy.

Angelini Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Angelini Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angelini Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angelini Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angelini Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angelini Group, Medical Devices Deals, 2012 to YTD 2018 9
Angelini Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Angelini Group, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Bristol-Myers Squibb May Sell UPSA to BC Partners, CVC Capital, PAI Partners, Angelini and STADA for USD1.16 Billion 11
Angelini Group - Key Employees 13
Angelini Group - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Angelini Group, Pharmaceuticals & Healthcare, Key Facts 2
Angelini Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angelini Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angelini Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angelini Group, Deals By Therapy Area, 2012 to YTD 2018 8
Angelini Group, Medical Devices Deals, 2012 to YTD 2018 9
Angelini Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bristol-Myers Squibb May Sell UPSA to BC Partners, CVC Capital, PAI Partners, Angelini and STADA for USD1.16 Billion 11
Angelini Group, Key Competitors 12
Angelini Group, Key Employees 13
Angelini Group, Subsidiaries 14
Angelini Group, Joint Venture 15

List Of Figures


Angelini Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Angelini Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Angelini Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Angelini Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Angelini Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angelini Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Angelini Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angelini Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angelini Group, Medical Devices Deals, 2012 to YTD 2018 9

Angelini Group - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control

USD 250 View Report

Angelini Group Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Angelini Group Company Profile is a detailed strategic and analytical report on Angelini Group. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Nexter Group - Strategy, SWOT and Corporate Finance Report

Nexter Group - Strategy, SWOT and Corporate Finance ReportNexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the

USD 175 View Report

The Techint Group - Strategy, SWOT and Corporate Finance Report

The Techint Group - Strategy, SWOT and Corporate Finance ReportThe Techint Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available